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There is accumulating data suggesting that the ischemic
stroke may be increased in patients with corona virus dis-
ease 2019 (COVID-19) due to hyper coagulopathy.1,2 An
increase in acute ischemic stroke patients who require
mechanical thrombectomy is to be expected particularly
in regions with high rates of COVID-19.1
We used national utilization data of a specific stent
retriever (TrevoTM. Stryker Neurovascular, Inc. Fremont,
California, United States), as a surrogate for mechanical
thrombectomy procedures, per month and for each state
since January 1 2019 to April 30, 2020. Although Stryker
Neurovascular, Inc kindly provided access to the national
device utilization information, they did not have any role
in the analysis of the data, or the writing of the present
communication. We calculated the median number of
mechanical thrombectomy performed per month based
on data from pre-COVID 12-month period (March 1, 2019
to February 29, 2020). We excluded 25 states where
median mechanical thrombectomy performed per month
in the pre-COVID 12-month period was 10 or less from
the primary analysis. As the monthly mechanical throm-
bectomy volume was not normally distributed, we used
one-sample two-tailed Wilcoxin signed rank test with
alpha = 0.05 to compare the number of mechanical throm-
bectomy performed in March and April 2020 with
monthly median value for pre-COVID 12-month period
for each of the respective 24 states. Compared with the
median value per month for pre-COVID 12-month period,
number of mechanical thrombectomy performed in
March 2020 was significantly lower in 7 states and higher
in 6 states, and not significantly different in 11 states. In
April 2020, the number of mechanical thrombectomy
compared with the median value per month for pre-
COVID 12-month period was significantly lower in 11
states, higher in 3 states, and not significantly different in
remaining 10 states. Interestingly the number of mechani-
cal thrombectomy performed in New York state, which
was most affected from COVID-19 was significantly
reduced in March 2020 (47 procedures), but not in April
2020 (52 procedures) compared to the median monthly
value of 58.5 procedures in pre-COVID 12-month period.
We identified the total number of COVID-19 cases (per
million) in each state at April 30th, 2020. The bar graph
(Fig. 1) demonstrates the change in number of mechanical
thrombectomy performed per state according to total
number of COVID-19 cases within respective state. There
was no relationship visualized between the total number
of COVID-19 cases in a state and change in number of
mechanical thrombectomy performed. In an Ad Hoc
exploratory analysis, the results were similar for 25 states
with an average of 10 or less procedures per month. In
March 2020, 5 states had reduction in number of mechani-
cal thrombectomy performed, 8 had an increase, and no
change was observed in 12 states. Whereas in April 2020,
11 states had had reduction in number of mechanical
thrombectomy performed, 2 states had an increase and no
change was observed in 12 states.
In general, we observed no change in March but an over-
all reduction in April 2020 in number of mechanical throm-
bectomy performed for acute ischemic stroke. There was a
variation between states in regards to change in number of
mechanical thrombectomy performed with most states
experiencing no change, an increasing proportion experienc-
ing a decrease, and a minority actually experiencing an
increase in mechanical thrombectomy performed. This
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Fig. 1. Box plot representing median, interquartile range, minimum and maximum values of mechanical thrombectomy performed in each state presented accord-
ing to COVID-19 cases within respective state (in ascending order from top to bottom). The red and green bars represent mechanical thrombectomy performed in
March and April, 2020, respectively. The diamond represents the mean value; Red bars with * if p < 0.05 for difference between March 2020 and median value
per month of pre-COVID 12-month period; Green bars with * if p < 0.05 between April 2020 and median value per month of pre-COVID 12-month period.
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change in number of mechanical thrombectomy performed
was not explained by differences in occurrence of COVID-
19 between states. We understand that TrevoTM stent
retriever is not the only device for use in mechanical throm-
bectomy but it is unlikely that practitioners will change
device preference due to COVID-19 pandemic and there-
fore, the observed changes are likely due to actual change in
numbers of mechanical thrombectomy performed. Plausible
reasons for the apparent reduction in performance of
mechanical thrombectomy during April 2020 include: a)
Delays in accessing specialized care, resulting in patients
presenting outside of the therapeutic window3, b) Reluc-
tance of acute ischemic stroke patients to present at emer-
gency departments4, and c) Reduction in stroke occurrence
during the COVID-19 pandemic as a result of mandated
social distancing. In regards to reluctance of patients to pres-
ent at emergency department, acute ischemic stroke patients
who require thrombectomy typically have severe neurologic
deficits and are unlikely to avoid hospitalization unlike
those with transient ischemic attack or minor deficits.3 Con-
cerning the possibility of an effect by mandated social dis-
tancing, this could reflect the reduction that such a practice
may have on exposure to a larger number of other respira-
tory tract infections that independently increase the risk of
ischemic stroke.4,5 Our data is reflective of early part of the
COVID-19 pandemic and additional changes may be seen
as the pandemic continues to evolve.
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